AstraZeneca Imfinzi in combo with chemotherapy gets USFDA approval for treatment of resectable non-small cell lung cancer before and after surgery Ruchika Sharma17 Aug 2024 1:30 PM ISTCambridge: AstraZeneca's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the US for the treatment of adult...
AstraZeneca Imfinzi gets USFDA priority review for limited-stage small cell lung cancer Ruchika Sharma16 Aug 2024 12:30 PM ISTCambridge: AstraZeneca's supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), based on the results from the positive...
Merck discontinues Phase 3 trial for lung cancer combo drug Ruchika Sharma11 Aug 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the Phase 3 KeyVibe-008 trial based on...
Insufficient evidence to recommend low-dose CT screening in never smokers lung cancer screening, finds research Dr. Kamal Kant Kohli7 Aug 2024 3:15 AM ISTLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early stages significantly improves survival...
EMA Committee recommends Rybrevant in combo with chemotherapy for adult patients with lung cancer after failure of prior therapy Ruchika Sharma4 Aug 2024 11:00 AM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
Vaping and smoking together increases lung cancer risk fourfold, reveals research Dr. Kamal Kant Kohli3 Aug 2024 7:15 AM ISTPeople who both vape and smoke are four times more likely to develop lung cancer than people who just smoke, according to new study published by The...
Diabetes drug reduces drug resistance in lung cancer and improves effectiveness of chemotherapy: Study Dr. Kamal Kant Kohli29 July 2024 1:15 AM ISTA medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new...
FDA Advisory Committee reviewed Imfinzi for resectable non-small cell lung cancer based on AEGEAN Phase III trial results Ruchika Sharma28 July 2024 4:15 PM ISTThe Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) has acknowledged that AstraZeneca's Imfinzi (durvalumab) met...
Zydus Lifesciences gets Mexican regulatory authority marketing nod for cancer drug Bhava Ruchika Sharma22 July 2024 2:59 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against...
JAMA Study Links E-Cigarette Use to Lower Lung Cancer Screening Rates Medha Baranwal19 July 2024 8:00 AM ISTUSA: A cross-sectional study published in JAMA Network Open revealed that e-cigarette use is independently associated with lower use of lung cancer...
Roche to halt lung cancer treatment trial Ruchika Sharma8 July 2024 5:43 PM ISTBased on these results, patients and investigators will be unblinded and we intend to halt the study.
Medical Bulletin 08/ July/ 2024 Anshika Mishra8 July 2024 3:00 PM ISTHere are the top medical news for the day:Smoking Identified as Major Contributor to Cognitive Decline in Older Adults: Study Smoking may be among...
